| Product NDC: | 21695-401 |
| Proprietary Name: | Amoxicillin and Clavulanate Potassium |
| Non Proprietary Name: | Amoxicillin and Clavulanate Potassium |
| Active Ingredient(s): | 600; 42.9 mg/5mL; mg/5mL & nbsp; Amoxicillin and Clavulanate Potassium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 21695-401 |
| Labeler Name: | Rebel Distributors Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065358 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070813 |
| Package NDC: | 21695-401-12 |
| Package Description: | 125 mL in 1 BOTTLE, DISPENSING (21695-401-12) |
| NDC Code | 21695-401-12 |
| Proprietary Name | Amoxicillin and Clavulanate Potassium |
| Package Description | 125 mL in 1 BOTTLE, DISPENSING (21695-401-12) |
| Product NDC | 21695-401 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Amoxicillin and Clavulanate Potassium |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20070813 |
| Marketing Category Name | ANDA |
| Labeler Name | Rebel Distributors Corp. |
| Substance Name | AMOXICILLIN; CLAVULANATE POTASSIUM |
| Strength Number | 600; 42.9 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |